Levofloxacina Eg

Levofloxacin, the active ingredient in Levofloxacina Eg, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adult patients, including urinary, respiratory, skin, and intra‑abdominal infections.

GNH USA supplies Levofloxacina Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in several organ systems.

Urinary tract infections: eradicates common uropathogens and resolves symptoms of cystitis and pyelonephritis. Community‑acquired respiratory infections: treats pneumonia, acute exacerbations of bronchitis and sinusitis caused by susceptible bacteria. Skin and soft‑tissue infections: clears cellulitis, abscesses and wound infections. Acute bacterial prostatitis: penetrates prostatic tissue to eliminate causative organisms. Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic bacteria in peritonitis and intra‑abdominal abscesses.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or unsteadiness. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, often linked to sudden activity. - QT interval prolongation: may predispose to cardiac arrhythmias. - Clostridioides difficile infection: severe colitis following disruption of gut flora. - Severe allergic reactions: anaphylaxis, skin rash, or angioedema. - Peripheral neuropathy: numbness or tingling in extremities. - Photosensitivity: heightened skin reaction to sunlight.

Levofloxacina Eg requires careful assessment of patient risk factors before use.

Renal function assessment: dose adjustment may be needed in impaired kidney function. Tendon disorder history: avoid in patients with prior tendon injury or who engage in high‑impact sports. QT prolongation monitoring: caution in patients with cardiac arrhythmias or on other QT‑prolonging drugs. Pregnancy and lactation: use only if clearly needed, as safety data are limited. Drug‑specific contraindications: avoid in patients with known hypersensitivity to fluoroquinolones. Store below 25°C: keep in the original container, protect from moisture and light.

Levofloxacina Eg can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: markedly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: elevated cyclosporine levels can lead to nephrotoxicity. - Theophylline: increased plasma concentrations may cause seizures or cardiac arrhythmias. - Glucose‑6‑phosphate dehydrogenase deficiency: risk of hemolysis.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use may raise the chance of central nervous system stimulation. - Corticosteroids: together increase tendon‑rupture risk. - Oral hypoglycemics or insulin: enhanced hypoglycemic effect. - SSRIs or SNRIs: potential for increased bleeding. - Diabetic agents: monitor blood glucose closely.